Recognition and Management of Metabolic Epilepsies - Takeaways - MDSpire

Recognition and Management of Metabolic Epilepsies

This video presents a clinically grounded overview of recent advances in neurogenetics and precision-based therapies for severe childhood-onset neurological disorders, including Dravet syndrome and related epileptic encephalopathies

  • April 7, 2026

Share

  • 1

    Recent advances in neurogenetics are enhancing the understanding of severe childhood-onset neurological disorders.

  • 2

    Single-gene mutations disrupt neuronal signaling and stability, leading to complex seizure phenotypes.

  • 3

    Traditional antiseizure therapies are limited, highlighting the need for disease-modifying approaches.

  • 4

    Emerging therapies include gene replacement, modulation, and RNA-based strategies with specific delivery challenges.

  • 5

    Rigorous clinical research and long-term follow-up are essential for the responsible translation of new therapies.

Original Source(s)

Recognition and Management of Metabolic Epilepsies

  • April 7, 2026

Related Content

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

Innovative, Minimally Invasive Treatment for Drug-Resistant Epilepsy

Epilepsy remains a life-altering condition, particularly due to the unpredictable nature of seizures and their cumulative impact on cognition, independence and quality of life.

  • May 8, 2026

  • 5 min
A transposase-derived gene required for human brain development

A groundbreaking study published in Science Advances and featuring Phoenix Children’s investigators Dr. Michael Kruer and Dr. Patricia Cornejo reveals a previously unknown requirement for somatic genetic diversity among neurons in normal brain development.

  • April 6, 2026

  • 2 min